Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
Clinical trial NCT06195670 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06195670
- Sponsor
- Zhejiang Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.